Literature DB >> 2255786

Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis.

N Milman1, O Selroos.   

Abstract

The review is based on studies of pulmonary sarcoidosis from Denmark, Finland and Sweden during 1950-1982, focusing on the course and prognosis of the disease. Cases with acute onset with chest X-ray stage I, fever, arthritis and erythema nodosum had a 85-90% remission rate during the first two years. The overall 5 year remission rate for stage I was 82%, stage II 66% and stage III 30%. Among cases with stage I, 2-5%, and among cases with stage II and III, 6-10% developed chronic pulmonary disease. Patients with stage I had a normal mortality rate, whereas those with stage II, III and IV had a rate threefold higher than expected due to sarcoidosis-related cardiopulmonary complications.

Entities:  

Mesh：

Year:  1990        PMID： 2255786

Source DB:  PubMed          Journal:  Sarcoidosis        ISSN： 0393-1447


  9 in total

1.  Outcome of pulmonary sarcoidosis: a population-based study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eva M Carmona; Eric L Matteson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors.

Authors:  H Visser; K Vos; E Zanelli; W Verduyn; G M Th Schreuder; I Speyer; F C Breedveld; J M W Hazes
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

3.  Sarcoidois: is it only a mimicker of primary rheumatic disease? A single center experience.

Authors:  Senol Kobak; Fidan Sever; Oya Nermin Sivrikoz; Mehmet Orman
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-02       Impact factor: 5.346

4.  Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: The Black Women's Health Study.

Authors:  Yvette C Cozier; Jeffrey S Berman; Julie R Palmer; Deborah A Boggs; Lauren A Wise; Lynn Rosenberg
Journal:  Am J Epidemiol       Date:  2012-09-11       Impact factor: 4.897

5.  The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis.

Authors:  Simon Blankley; Christine M Graham; Jacob Turner; Matthew P R Berry; Chloe I Bloom; Zhaohui Xu; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Ronan Breen; George Santis; Derek M Blankenship; Marc Lipman; Anne O'Garra
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

6.  First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative.

Authors:  Nynke A Kampstra; Jan C Grutters; Frouke T van Beek; Daniel A Culver; Robert P Baughman; Elisabetta A Renzoni; Wim Wuyts; Vaslis Kouranos; Marlies S Wijsenbeek; Douwe H Biesma; Philip J van der Wees; Paul B van der Nat
Journal:  BMJ Open Respir Res       Date:  2019-02-18

7.  Sarcoidosis in Iceland: a nationwide study of epidemiology, clinical picture and environmental exposure.

Authors:  Sigríður Ólína Haraldsdóttir; Jon Gunnlaugur Jonasson; Kristin Bara Jorundsdottir; Haraldur Jon Hannesson; Thorarinn Gislason; Bjorn Gudbjornsson
Journal:  ERJ Open Res       Date:  2021-12-13

8.  Clinical characteristics and computed tomography findings in Arab patients diagnosed with pulmonary sarcoidosis.

Authors:  Esam H Alhamad; Mohammed O Alanezi; Majdy M Idrees; Mohammad K Chaudhry; Ali M AlShahrani; Arthur Isnani; Shaffi Shaikh
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526

9.  Silica dust and sarcoidosis in Swedish construction workers.

Authors:  E Jonsson; B Järvholm; M Andersson
Journal:  Occup Med (Lond)       Date:  2019-12-07       Impact factor: 1.611
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.